Insider Transactions in Q2 2025 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2025
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
24,193
+9.3%
|
-
|
|
Jun 10
2025
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+16.46%
|
-
|
|
Jun 10
2025
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+17.73%
|
-
|
|
Jun 10
2025
|
Mark G Currie |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+6.83%
|
-
|
|
Jun 10
2025
|
Jon R Duane |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+19.12%
|
-
|
|
Jun 10
2025
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+27.62%
|
-
|
|
Jun 10
2025
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+20.78%
|
-
|
|
Jun 10
2025
|
Marla L Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+21.34%
|
-
|
|
Jun 10
2025
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+17.53%
|
-
|
|
May 20
2025
|
Thomas A Mccourt Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
540,000
+24.24%
|
-
|
|
May 16
2025
|
Tammi L Gaskins Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,563
-1.05%
|
$0
$0.58 P/Share
|
|
May 16
2025
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,353
-1.15%
|
$0
$0.58 P/Share
|
|
Apr 02
2025
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
10,416
+5.88%
|
-
|